Stockreport

Worries Mount Over Cancer Risks in Bluebird Bio's Gene Therapy [Yahoo! Finance]

bluebird bio, Inc.  (BLUE) 
Last bluebird bio, inc. earnings: 2/18 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.bluebirdbio.com/investor-overview
PDF Bio Inc's (NASDAQ: BLUE ) gene therapy for a severe neurological disorder in clinical trials have developed blood cancers. This marks an increase of four cases since J [Read more]